Overview
Serum Alpha-fetoprotein Levels and Response to Direct Antiviral Therapy in Patients With Chronic Hepatitis C
Status:
Recruiting
Recruiting
Trial end date:
2022-12-30
2022-12-30
Target enrollment:
0
0
Participant gender:
All
All
Summary
Alpha-fetoprotein Levels on the Response to direct Antiviral Therapy in Patients with Chronic Hepatitis CPhase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Sherief Abd-ElsalamTreatments:
Antiviral Agents
Ledipasvir
Ledipasvir, sofosbuvir drug combination
Sofosbuvir
Criteria
Inclusion Criteria:- HCV patients who will undergo treatment by direct acting antiviral agents.
Exclusion Criteria:
- Patients with decompensated liver disease